Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?

International Journal of Radiation Oncology Biology Physics

Volumn 88, Issue 1, 2014, Pages 57-64

  Truong, Pauline T ^a   Sadek, Betro T ^b   Lesperance, Maria F ^a   Alexander, Cheryl S ^a   Shenouda, Mina ^b   Raad, Rita Abi ^b   Taghian, Alphonse G ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTEMPORARY PRACTICES; LOCOREGIONAL RECURRENCE; MARGIN STATUS; METHODS AND MATERIALS; MULTIVARIABLE ANALYSIS; NODE-NEGATIVE; POSTMASTECTOMY RADIATION THERAPIES; TRIPLE-NEGATIVE BREAST CANCERS;

DISEASES; HISTOLOGY; RADIOTHERAPY; TUMORS;

RISK ASSESSMENT;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE RISK; SYSTEMIC THERAPY; TRIPLE NEGATIVE BREAST CANCER; TUMOR VOLUME;

ANALYSIS OF VARIANCE; AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR BURDEN;

EID: 84890563618     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.09.024     Document Type: Conference Paper

References (35)

1. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 2000 747 752
2. T. Sorlie, R. Tibshirani, and J. Parker Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A 100 2003 8418 8423
3. P. Tang, K.A. Skinner, and D.G. Hicks Molecular classification of breast carcinomas by immunohistochemical analysis: Are we ready? Diagn Mol Pathol 18 2009 125 132
4. P.L. Nguyen, A.G. Taghian, and M.S. Katz Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast conserving therapy J Clin Oncol 26 2008 2373 2378
5. N.D. Arvold, A.G. Taghian, and A. Niemierko Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy J Clin Oncol 29 2011 3885 3891
6. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials Lancet 366 2005 2087 2106
7. A. Goldhirsch, J.N. Ingle, and R.D. Gelber Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 Ann Oncol 20 2009 1319 1329
8. M. Kyndi, M. Overgaard, and H.M. Nielsen High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c Radiother Oncol 90 2009 74 79
9. H. Trihia, S. Murray, and K. Price Ki-67 expression in breast carcinoma: Its association with grading systems, clinical parameters, and other prognostic factors - a surrogate marker? Cancer 97 2003 1321 1331
10. A. Goldhirsch, W.C. Wood, and A.S. Coates Strategies for subtypes: dealing with the diversity of breast cancer: Highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2011 Ann Oncol 22 2011 1736 1747
11. M.J. Piccart-Gebhart, M. Procter, and B. Leyland-Jones Trastuzumab after adjuvant chemotherapy in HER-2-positive breast cancer N Engl J Med 353 2005 1659 1672
12. E.H. Romond, E.A. Perez, and J. Bryant Trastuzumab plus adjuvant chemotherapy for operable HER-2-positive breast cancer N Engl J Med 353 2005 1673 1684
13. B.G. Haffty, Q. Yang, and M. Reiss Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 2006 5652 5657
14. G.M. Freedman, P.R. Anderson, and T. Li Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation Cancer 115 2009 946 951
15. J. Selz, D. Stevens, and L. Jouanneau Prognostic value of molecular subtypes, Ki67 expression, and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy Int J Radiat Oncol Biol Phys 84 2012 1123 1132
16. H. Mersin, K. Gulben, and U. Berberoglu Prognostic factors affecting postmastectomy locoregional recurrence in patients with early breast cancer: Are intrinsic subtypes effective? World J Surg 35 2011 2196 2202
17. L.S. Dominici, E.A. Mittendorf, and X. Wang Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy Breast Cancer Res 14 2012 R32
18. R. Dent, M. Trudeau, and K.I. Pritchard Triple-negative breast cancer: Clinical features and patterns of recurrence Clin Cancer Res 13 2007 4429 4434
19. J.E. Panoff, J. Hurley, and C. Takita Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation Breast Cancer Res Treat 128 2011 899 906
20. Z. Gabos, J. Thoms, and S. Ghosh The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer Breast Cancer Res Treat 124 2010 187 194
21. D.K. Voduc, M.C. Cheang, and S. Tyldesley Breast cancer subtypes and the risk of local and regional relapse J Clin Oncol 28 2010 1684 1691
22. B.S. Abdulkarim, J. Cuartero, and J. Hanson Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy J Clin Oncol 29 2011 2852 2858
23. X. Chen, X. Yu, and J. Chen Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: Patterns of failure and prognostic factors Cancer 119 2013 2366 2374
24. A.Y. Ho, G. Gupta, and T.A. King Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy Cancer 118 2012 4944 4952
25. Z.S. Zumsteg, M. Morrow, and B. Arnold Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer Ann Surg Oncol 20 2013 3469 3476
26. F.C. Adkins, A.M. Gonzalez-Angulo, and X. Lei Triple-negative breast cancer is not a contraindication for breast conservation Ann Surg Oncol 18 2011 3164 3173
27. P.T. Truong, M. Lesperance, and A. Culhaci Patient subsets with T1-2, node-negative breast cancer at high locoregional recurrence risks after mastectomy Int J Radiat Oncol Biol Phys 62 2005 175 182
28. R. Jagsi, R.A. Raad, and S. Goldberg Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: Implications for postmastectomy radiation Int J Radiat Oncol Biol Phys 62 2005 1035 1039
29. R. Abi-Raad, R. Boutrus, and R. Wang Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: Implications for postmastectomy radiotherapy Int J Radiat Oncol Biol Phys 81 2011 e151 e157
30. E. Yildirim, and U. Berberoglu Can a subgroup of node-negative breast carcinoma patients with T1-2 tumor who may benefit from postmastectomy radiotherapy be identified? Int J Radiat Oncol Biol Phys 68 2007 1024 1029
31. J.M. Albert, G.M. Gonzalez-Angulo, and M. Guray Estrogen/progesterone receptor negativity and Her2 positivity predict locoregional recurrence in patients with pT1a, bN0 breast cancer Int J Radiat Oncol Biol Phys 77 2010 1296 1302
32. S.K. Childs, Y.H. Chen, and M. Duggan Surgical margins and the risk of local-regional recurrence after mastectomy without radiation therapy Int J Radiat Oncol Biol Phys 84 2012 1133 1138
33. J. Wang, M. Shi, and R. Ling Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: A prospective randomized controlled multi-center trial Radiother Oncol 100 2011 200 204
34. A. Prat, B. Adamo, and M.C. Cheang Molecular characterization of basal-like and non-basal-like triple-negative breast cancer Oncologist 18 2013 123 133
35. B.G. Haffty, and T.A. Buchholz Molecular predictors of locoregional recurrence in breast cancer: Ready for prime time? J Clin Oncol 28 2010 1627 1629